BioMarin Pharmaceutical, Inc. (BMRN)

Phileas100 (91.82) Submitted: 4/18/07 9:29 AM : Start Price: $16.50 BMRN Score: 69.81

This company is doing good research in drugs that address orphan desaeses (those that no other labs are paying attention to). This provides a wide moat.





They issued convertible notes that may dilute EPS in the future, but I am confident the managment will make good use of the cash.

Report this Post Replies: 0 | Reply